Compound E, chemically designated as 209986-17-4 (CAS), represents a significant study within the field of Alzheimer's condition research. This γ-secretase modulator was initially developed as a possible therapeutic https://joycejrwd437572.mpeblog.com/73260612/γ-secretase-inhibitor-compound-e-209986-17-4